We trade on the OTC Market under the symbol FORW.
Note: On February 25, 2021 – HUMBLPay Inc. initiated a 4:1 Reverse Split in their common shares. The 500 million warrant shares that Forwardly, Inc held were reduced accordingly to 125 million warrant shares. The warrant shares are convertible at .20/share until December 2023.
• a wholly owned subsidiary corporation
June 1, 2020 Forwardly, Inc. formed "Breathe
Medical Devices, Inc.", a wholly owned Wyoming corporation.
This subsidiary will be the operating arm for Forwardly's recent acquisition of the exclusive US distribution rights to LifeAir™, a patent pending,
non-invasive ventilator currently under development by Ligand Innovation Global, a Canadian
corporation. A newer iteration of the LifeAir ventilator is currently being engineered for a summer 2020 submission to the US Food and Drug Administration ("FDA") and Canada Health in the hopes
of obtaining fast track approval. A demonstration of a prototype of the LifeAir ventilator is available for viewing at www.LigandGlobal.com or www.BreatheMedicalDevices.com.
Management has an option to purchase up to 25% of Ligand Innovation Global following FDA approval of the ventilator.
The new subsidiary will at least initially be managed by Mr. Sharp, however, the company is currently reviewing the new asset with several prominent doctors and has formed a Medical Advisory Board.
Forwardly, Inc.
3535 Executive Terminal Drive, Suite 110
Henderson, NV 89052
702.840.4433
Email: info@ForwardlyPlaced.com